Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-06-25 17:14:55 ET · period of report 2026-06-23 · accession 0001852291-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-25 17:14 | 2026-06-23 | ONC | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $276.74 | -1,068 | 0 | -100% | -$295.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-06-23 | S | D | 1,068 | $276.74 | 0 | D | — | — | (F5) Each American Depositary Share represents 13 Ordinary Shares. (F6) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |